Cargando…
What’s New in Arrhythmogenic Cardiomyopathies
Autores principales: | Çimen, Tolga, Saguner, Ardan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409703/ https://www.ncbi.nlm.nih.gov/pubmed/36013003 http://dx.doi.org/10.3390/jcm11164764 |
Ejemplares similares
-
Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy
por: van der Voorn, Stephanie M., et al.
Publicado: (2023) -
A Novel Heterozygous Desmoplakin Variant Causes Cardiocutaneous Syndrome with Arrhythmogenic Cardiomyopathy and Palmoplantar Keratosis
por: Çimen, Tolga, et al.
Publicado: (2023) -
Biventricular Arrhythmogenic Cardiomyopathy Associated with a Novel Heterozygous Plakophilin-2 Early Truncating Variant
por: Çimen, Tolga, et al.
Publicado: (2022) -
Familial Arrhythmogenic Cardiomyopathy: Clinical Determinants of Phenotype Discordance and the Impact of Endurance Sports
por: Costa, Sarah, et al.
Publicado: (2020) -
Arrhythmogenic Cardiomyopathy: from Preclinical Models to Genotype–phenotype Correlation and Pathophysiology
por: Fan, Xuehui, et al.
Publicado: (2023)